drugset / Trial / NCT00004161
Fenretinide in Treating Patients With Leukoplakia of the Mouth
Phase 2
Completed
30 enrolled
University of Alabama at Birmingham
National Cancer Institute (NCI) · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of or treat early cancer. Fenretinide may be an effective drug in treating leukoplakia. PURPOSE: Randomized phase II trial to study the effectiveness of fenretinide in treating patients who have leukoplakia of the mouth.
Timeline
- Start
- 1997-06
- Primary completion
- 2004-01
- Completion
- 2004-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fenretinide | Small molecule | — | Oral |